Brief: Novo Integrated Sciences Acquires Majority Stake In Terragenx And Intellectual Property For FDA And Health Canada Approved Water-Soluble Iodine Micro-Nutrient
30/11/2021 13:28
Nov 30 (Reuters) - Novo Integrated Sciences Inc NVOS.O :
* NOVO INTEGRATED SCIENCES ACQUIRES MAJORITY STAKE IN
TERRAGENX
AND INTELLECTUAL PROPERTY FOR FDA AND HEALTH CANADA APPROVED
WATER-SOLUBLE IODINE MICRO-NUTRIENT
* NOVO INTEGRATED SCIENCES INC - ACQUIRED A 91% INTEREST IN
TERRAGENX THROUGH AN ALL-SHARE TRANSACTION AT $3.35 PER SHARE
WHICH CLOSED NOVEMBER 17
* NOVO INTEGRATED SCIENCES INC - ACQUIRED IODINE IP AND
PATENTS
FROM TERENCE MULLINS IN ALL-SHARE TRANSACTION AT $3.35 PER SHARE
ON NOVEMBER 17
Source text for Eikon: ID:nBw9hYbQpa
Further company coverage: NVOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novo Integrated Sciences
See all newsBrief: Novo Integrated Sciences Says On Nov 4, Got Letter From Nasdaq Indicating Co's Common Stock Will Be Delisted From Nasdaq
Brief: Novo Integrated Sciences Gets Commencement Of Disbursement Notice For SBLC Leasing And Monetizing Program
Brief: Novo Integrated Sciences Inc Files For Offering Of 3.5 Million Shares Of Common Stock By Selling Securityholder - SEC Filing
Brief: Novo Integrated Sciences Receives Confirmation Of Issuance Of SBLC By HSBC
U.S. STOCKS ON THE MOVE-Nordstrom, Foot Locker, VF Corp